OncoTrap logo — Pioneering the future of cancer treatment by harnessing the...

OncoTrap

Pioneering the future of cancer treatment by harnessing the power of the immune system to eradicate tumors.

Founded 2016 Grant Total: $75.00K Biotechnology

General Information

Company Name OncoTrap
Founded Year 2016
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with OncoTrap. To contact OncoTrap, visit oncotrap.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About OncoTrap

OncoTrap is a pioneering biotechnology startup founded in 2016, with a mission to revolutionize cancer treatment by leveraging the immune system to eliminate tumors. The company is dedicated to developing innovative therapies that stimulate the immune system to reduce tumor burden. Utilizing in vivo nucleic delivery and advanced protein engineering techniques, OncoTrap enables healthcare professionals to administer therapeutic genes directly to tumor sites, presenting a promising approach in the field of biotechnology. The most recent investment in OncoTrap amounted to $75.00K in the form of a grant, which was secured on 22 September 2022. The investment was provided by the One North Carolina Small Business Program, demonstrating confidence in the potential of OncoTrap's innovative technology and treatment approach within the biotechnology sector. This funding is expected to further propel the company's research and development efforts, as well as support its trajectory towards making significant strides in cancer treatment.

Taxonomy: Cancer treatment, Immune system, Tumor eradication, Therapeutic genes, Protein engineering, In vivo nucleic delivery, Healthcare innovation, Immunotherapy, Cancer research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $75.00K 1
One North Carolina Small Business Program
22 Sep 2022

OncoTrap Alternatives & Competitors

OncoTrap vs

Harnessing the power of the immune system to develop treatments for cancer.

23 employees
Biotechnology
OncoTrap vs

Unlocking the power of the immune system - next-generation immunotherapy

Venture round
12 employees
Biotechnology, Life Sciences
OncoTrap vs

Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the power of t...

Seed
1 employees
Biotechnology, Health and Wellness
Also compare with: OncoTrap vs Umoja Biopharma Umoja Biopharma

FAQ About OncoTrap

Pioneering the future of cancer treatment by harnessing the power of the immune system to eradicate tumors.
OncoTrap was founded in 2016.
OncoTrap operates in Biotechnology. Its work centres on Cancer treatment, Immune system, Tumor eradication and Therapeutic genes.
OncoTrap has completed 1 funding round, raising a total of $75.00K. The latest funding stage is Grant.
Top alternatives and competitors to OncoTrap include Tizona Therapeutics, Inc., Nectin Therapeutics, Taiga Biotechnologies, Boostimmune, Modifi Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OncoTrap and Tizona Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OncoTrap, https://bouncewatch.com/company/oncotrap, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes